What is the latest ALKEM stock price?
The latest stored price for ALKEM is Rs 5,136.00 as of 2026-11-16.
ALKEM LABORATORIES LTD. is a mid-cap stock in Healthcare. This Gimli page shows the latest available ALKEM price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
The latest stored price for ALKEM is Rs 5,136.00 as of 2026-11-16.
ALKEM is below 50DMA, below 200DMA. The latest 50DMA is 5,201.73 and the latest 200DMA is 5,417.56.
ALKEM has PE 29.35, ROE +15.55%, and ROCE +21.03% in Gimli's latest available snapshot.
ALKEM has returned +1.70% over 1 month, -4.32% over 3 months, and -10.25% over 12 months in the latest stored data.
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-09-30 | 4,551.99 cr | 1,194.40 cr | 675.34 cr | 56.48 |
| 2026-06-30 | 3,740.15 cr | 918.80 cr | 519.96 cr | 43.49 |
| 2026-03-31 | 3,603.32 cr | 582.49 cr | 251.10 cr | 19.77 |
| 2025-12-31 | 3,736.82 cr | 918.31 cr | 636.02 cr | 53.19 |
| 2025-09-30 | 4,000.99 cr | 1,024.46 cr | 765.06 cr | 63.99 |
| 2025-06-30 | 3,371.14 cr | 888.47 cr | 664.26 cr | 55.56 |
| 2025-03-31 | 3,143.75 cr | 537.25 cr | 305.86 cr | 25.57 |
| 2024-12-31 | 3,374.28 cr | 852.38 cr | 625.82 cr | 52.34 |
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 14,712.27 cr | 3,413.73 cr | 2,301.80 cr | 192.51 |
| 2025-03-31 | 12,964.52 cr | 3,005.89 cr | 2,165.48 cr | 181.11 |
| 2024-03-31 | 12,439.24 cr | 2,418.14 cr | 1,795.77 cr | 150.19 |
| 2023-03-31 | 11,440.35 cr | 1,708.94 cr | 984.17 cr | 82.31 |
| 2022-03-31 | 9,029.70 cr | 2,189.08 cr | 1,541.25 cr | nan |
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 20,872.97 cr | 247.91 cr | 2,047.16 cr | 14,348.93 cr |
| 2025-03-31 | 17,691.10 cr | 304.14 cr | 1,380.90 cr | 12,433.63 cr |
| 2024-03-31 | 15,574.90 cr | 455.07 cr | 1,418.41 cr | 10,714.40 cr |
| 2023-03-31 | 13,756.65 cr | 273.80 cr | 1,396.68 cr | 9,435.00 cr |
| 2022-03-31 | 14,069.19 cr | 232.18 cr | 2,668.19 cr | 8,847.33 cr |
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | 1,963.03 cr | 1,345.77 cr | n/a |
| 2025-03-31 | 1,912.84 cr | 1,237.22 cr | n/a |
| 2024-03-31 | 1,948.07 cr | 1,688.78 cr | n/a |
| 2023-03-31 | 1,682.50 cr | 1,449.59 cr | n/a |
| 2022-03-31 | 1,111.02 cr | 772.14 cr | n/a |
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +49.70% | +10.42% | +22.63% | +16.71% | +17.25% | +0.00% |
| 2026-03-31 | +51.20% | +10.16% | +21.40% | +15.57% | +17.25% | +0.00% |
| 2025-12-31 | +51.20% | +9.97% | +21.54% | +16.06% | +17.30% | +0.00% |
| 2025-09-30 | +51.20% | +9.48% | +21.93% | +16.94% | +17.40% | +0.00% |
| 2025-06-30 | +53.04% | +9.11% | +21.80% | +16.67% | +16.05% | +0.00% |
| 2025-03-31 | +55.13% | +9.41% | +19.42% | +14.97% | +16.05% | +0.00% |
| 2024-12-31 | +55.66% | +10.15% | +18.01% | +14.01% | +16.18% | +0.00% |
| 2024-09-30 | +55.66% | +9.02% | +19.21% | +14.94% | +16.10% | +0.00% |
| 2024-06-30 | +56.38% | +8.69% | +18.57% | +14.72% | +16.36% | +0.00% |
| 2024-03-31 | +56.74% | +9.11% | +15.63% | +11.92% | +18.52% | +0.00% |
| 2023-12-31 | +56.74% | +8.49% | +15.91% | +12.08% | +18.86% | +0.00% |
| 2023-09-30 | +56.74% | +6.03% | +17.64% | +13.05% | +19.59% | +0.00% |
| 2023-06-30 | +57.16% | +5.64% | +16.34% | +11.45% | +20.86% | +0.00% |
| 2023-03-31 | +57.16% | +4.44% | +16.69% | +10.19% | +21.70% | +0.00% |
| 2022-12-31 | +57.16% | +4.41% | +16.44% | +10.06% | +21.99% | +0.00% |
| 2022-09-30 | +57.16% | +4.46% | +15.74% | +9.42% | +22.65% | +0.00% |
| 2022-06-30 | +57.14% | +0.00% | +19.77% | n/a | n/a | n/a |
| 2022-03-31 | +57.13% | +0.00% | +19.55% | n/a | n/a | +0.00% |
| 2021-12-31 | +57.13% | +0.00% | +19.34% | n/a | n/a | +0.00% |
| 2021-09-30 | +58.84% | +0.00% | +19.32% | n/a | n/a | +0.00% |
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| SUNPHARMA | SUN PHARMACEUTICAL IND L | 448,075.81 cr | 40.781879 | +14.03% | +6.28% |
| DIVISLAB | DIVI S LABORATORIES LTD | 294,139.21 cr | 87.463339 | +21.13% | +70.16% |
| TORNTPHARM | TORRENT PHARMACEUTICALS L | 178,438.17 cr | 85.011038 | +16.67% | +22.43% |
| APOLLOHOSP | APOLLO HOSPITALS ENTER. L | 126,113.56 cr | 53.952325 | +24.95% | +18.20% |
| LAURUSLABS | LAURUS LABS LIMITED | 119,848.17 cr | 89.960566 | +26.71% | +122.22% |
| ZYDUSLIFE | ZYDUS LIFESCIENCES LTD | 118,902.46 cr | 27.636309 | +15.44% | +26.21% |
| DRREDDY | DR. REDDY S LABORATORIES | 114,723.24 cr | 41.579949 | +7.80% | +10.59% |
| CIPLA | CIPLA LTD | 112,647.78 cr | 39.472630 | +8.80% | -8.98% |
Data snapshot: 2026-11-16. Not investment advice.